ClinicalTrials.Veeva

Menu

Specialized Treatment, Rehabilitation and Outcome in Patients With Prolonged Critical Illness (CritillPro)

R

Remeo AB

Status

Enrolling

Conditions

Critical Illness

Study type

Observational

Funder types

Other

Identifiers

NCT04247607
Dnr 2019-05294 (Other Identifier)
2019120000

Details and patient eligibility

About

This prospective observational study aims to describe the outcome for patients with persistent or chronic critical illness treated at Remeo, a clinic specialized for patients in need of prolonged intensive care and intensive care rehabilitation in Sweden. Patients' disease characteristics and the treatment in multidisciplinary patient centered teams for intensive care, weaning from mechanical ventilation and simultaneous rehabilitation will be described. Patients will be followed one year after discharge to document health related quality of life, physical function, frailty, mental illness and used health care resources.

Enrollment

250 estimated patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Admission to unit (Remeo, Stockholm, Sweden) Treated for prolonged critical illness

Exclusion criteria

Treated less than 48 hours at unit (Remeo, Stockholm, Sweden)

Trial contacts and locations

1

Loading...

Central trial contact

Eva Sundman, MD, PhD; Anna Cedborg, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems